Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #771

    GM. draft ASH Top 10 ( 859, 860, 862, 925 are Dara ) https://twitter.com/mtmdphd/status/1193260261160951808 https://www.myeloma.org/cure-blog/ash-top-10-2019-immune-therapies-again-dominate-news
    https://twitter.com/szusmani/status/1192582644170665984

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #772

      Thx E L. Looks like a bit of a revival of the CAR-t approach with the new CRISPR technology and bispecific CAR-t coming up.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #773

        But according to Durie the bb21217 isn't better than the original bb2121?

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #774

          Durie doesn't mention #930, the bispecific car-t, that Usmani emphasizes.

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #775

            Dara + ATRA disappointing: Overall, this approach resulted in a modest prolongation of PFS. Patients with primary DARA-refractory disease did not benefit from the addition of ATRA. However, in patients with ≥PR on DARA monotherapy prior to progression, addition of ATRA and re-intensification of DARA was of marked clinical benefit with an additional 7.8 months of disease control. https://ash.confex.com/ash/2019/webprogram/Paper123383.html

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #776

              Det var da heller ikke den værste udgang. Nu kan man hjælpe dem der ikke repondere.

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #777

                Men ærgerligt at man ikke kan finde et alternativ til revlimid.

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #778

                  Men deres patent har ikke så lang levetid mere. 😉 https://www.biopharmadive.com/news/celgene-revlimid-patent-challenge-dr-reddys-ptab/548172/

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #779

                    Jeg kan ikke se det er ændret ...

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #780

                      Just a moment...

                      favicon

                      (www.proinvestor.com)

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #781

                        God morgen. 🙂

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bibob
                          wrote on sidst redigeret af
                          #782

                          God morgen. :-).

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bibob
                            wrote on sidst redigeret af
                            #783

                            Merck and Pfizer's PD-L1 Bavencia ( avelumab ) fejler et PH III forsøg i gastric cancer. https://m.firstwordpharma.com/merck-kgaa-pfizer-say-late-stage-study-bavencio-gastric-cancer-misses-primary-endpoints

                            1 Reply Last reply
                            0
                            • T Offline
                              T Offline
                              transalp
                              wrote on sidst redigeret af
                              #784

                              Go morgen.. 🙂

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                mobbyduck1
                                wrote on sidst redigeret af
                                #785

                                voldsom omsætning

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  Michael_Almskov
                                  wrote on sidst redigeret af
                                  #786

                                  ja køberne er vedholdende her til morgen 😉

                                  1 Reply Last reply
                                  0
                                  • M Offline
                                    M Offline
                                    Michael_Almskov
                                    wrote on sidst redigeret af
                                    #787

                                    knapt 4000 handlede aktier i minuttet, for de første 12 minutter, det er sjældent det sker 🙂

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #788

                                      84 millioner omsat på tyve minutter. Det er en sjat.

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #789

                                        99 mio på 30 minutter.

                                        1 Reply Last reply
                                        0
                                        • H Offline
                                          H Offline
                                          henrikfrost111
                                          wrote on sidst redigeret af
                                          #790

                                          Der er nogle opgørelser over (jeg har ikke lige styr på hvor), hvilket GAK shorter-fondene sidder med. Er der nogen som ligger inde med dette overblik og kan dele. Kunne være interessant at vide hvor mange shortere som brænder inde...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger